News Headlines

  1. Science 37® Partners With Advarra To Expedite Virtual Trial Research For COVID-19 4/21/2020

    Science 37, the industry leader in decentralized clinical trials, and Advarra, a leading institutional review board (IRB), have partnered to expedite approvals on COVID-19–related virtual trials.

  2. Advarra Joins Leading Healthcare Companies To Announce COVID-19 Research Database 4/21/2020

    A consortium of leading healthcare companies today announced the launch of the COVID-19 Research Database, a secure repository of HIPAA-compliant, de-identified and limited patient-level data sets made available to public health and policy researchers to extract insights to help combat the COVID-19 pandemic.

  3. Advarra Acquires IRBco 4/20/2020

    Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC), research technology solutions, and quality and compliance consulting services is pleased to announce the acquisition of IRB Company, Inc. (IRBco), an AAHRPP-accredited central IRB that has conducted research reviews in the U.S. since 1981.

  4. Advarra Announces Appointment Of Gadi Saarony As Chief Executive Officer 4/15/2020

    Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC), research quality and compliance consulting services, and standards-based research technology solutions announced today the appointment of Gadi Saarony as Chief Executive Officer.

  5. TrialScope Video A WEGO Health Patient-Choice Awards Winner 4/14/2020

    TrialScope’s “Real Patient Stories: The Trials of Finding Clinical Trials” video has won a Silver award in the WEGO Health Patient-Choice Awards for Most Authentic Use of Patients in a Marketing Campaign.

  6. Leading Life Sciences And Information Technology Companies Join EndPandemic National Data Consortium To Integrate COVID-19 Clinical Data 4/14/2020

    The EndPandemic National Data Consortium announced today that it has received commitments from six leading life sciences and information technology companies to join the Consortium, the formation of which was announced on March 30, 2020.

  7. Advarra Technology Keeps Research Moving During COVID-19 Pandemic At Academic Institutions 4/13/2020

    Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC), research quality and compliance consulting services, and technology, today shared progress made by customers utilizing the company’s products and services to keep research moving forward during the COVID-19 pandemic.

  8. FDA Grants CalciMedica Permission To Begin Dosing CM4620-IE In Patients With Severe COVID-19 Pneumonia Under A Newly Opened IND 4/9/2020

    CalciMedica Inc. (“CalciMedica” or the “Company), a clinical-stage biotechnology company targeting calcium release-activated calcium (CRAC) channels for the treatment of acute and severe inflammatory diseases, today announced it has received a “Study May Proceed” letter from the U.S. Food and Drug Administration (FDA) to investigate the use of CM4620-IE in patients with severe COVID-19 pneumonia who are at risk for progression to acute respiratory distress syndrome (ARDS).

  9. 4G Clinical Launches Direct-To-Patient (DtP) Clinical Trial Platform 4/9/2020

    4G Clinical today announced the launch of a Direct-to-Patient (DtP) clinical trial platform, offering sponsors the flexibility to ship drug directly from the site, depot and/or central pharmacy to the patient's home.

  10. Survey Shows One Third Of Clinical Trial Study Sites Fear Total Closure; 77% Indicate At Least Some Ongoing Research Trials Have Been Impacted Due To COVID-19 4/8/2020

    An ongoing quantitative survey conducted by Continuum Clinical in partnership with the Association of Clinical Research Professionals (ACRP) shows 31% of clinical research study sites fear total closure as COVID-19-related stay-at-home orders and patient concerns over interacting with healthcare professionals continue to increase.